Indian drugmaker Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Novo Nordisk A/S’s Ozempic in March ...
By Kashish Tandon and Rishika Sadam Jan 23 (Reuters) - Sun Pharmaceutical Industries, India's top drugmaker by revenue, said on Friday it has received a regulatory nod to manufacture and sell ...
By Rishika Sadam and Kashish Tandon Jan 23 (Reuters) - Indian drugmakers Sun Pharmaceutical Industries, Zydus Lifesciences and Alkem Laboratories have received approval from India's regulator to ...
Dr Reddy's Laboratories is set to introduce a generic version of the weight-loss drug, Ozempic, in India post patent expiry, potentially halving its price.
Dr Reddy's Laboratories reported a 14% decline in profit after tax due to reduced sales in the US, despite an increase in ...
WASHINGTON, DC - APRIL 2: President Donald Trump signs an executive order imposing tariffs on imported goods during a "Make America Wealthy Again" trade announcement event in the Rose Garden at the ...
Mylan Pharmaceuticals Inc. will have to face antitrust claims that it conspired with other drugmakers to inflate generic drug ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. For the first time, a generic GLP-1 has been approved by ...